453 related articles for article (PubMed ID: 3569765)
1. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.
Sutherland LR; Martin F; Greer S; Robinson M; Greenberger N; Saibil F; Martin T; Sparr J; Prokipchuk E; Borgen L
Gastroenterology; 1987 Jun; 92(6):1894-8. PubMed ID: 3569765
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada.
Sutherland LR; Martin F
Dig Dis Sci; 1987 Dec; 32(12 Suppl):64S-66S. PubMed ID: 3319459
[TBL] [Abstract][Full Text] [Related]
3. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis.
Mantzaris GJ; Hatzis A; Petraki K; Spiliadi C; Triantaphyllou G
Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749
[TBL] [Abstract][Full Text] [Related]
4. Mesalamine for ulcerative colitis.
Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508
[No Abstract] [Full Text] [Related]
5. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.
Campieri M; De Franchis R; Bianchi Porro G; Ranzi T; Brunetti G; Barbara L
Scand J Gastroenterol; 1990 Jul; 25(7):663-8. PubMed ID: 2204103
[TBL] [Abstract][Full Text] [Related]
6. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
Frühmorgen P; Demling L
Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
[TBL] [Abstract][Full Text] [Related]
7. [5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial].
Ngô Y; Rambaud JC
Gastroenterol Clin Biol; 1992; 16(6-7):558-63. PubMed ID: 1526418
[TBL] [Abstract][Full Text] [Related]
8. Distribution of mesalamine enemas in patients with active distal ulcerative colitis.
Chapman NJ; Brown ML; Phillips SF; Tremaine WJ; Schroeder KW; Dewanjee MK; Zinsmeister AR
Mayo Clin Proc; 1992 Mar; 67(3):245-8. PubMed ID: 1545592
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
10. Mesalamine in ulcerative colitis.
Fitzgerald JM; Marsh TD
DICP; 1991 Feb; 25(2):140-5. PubMed ID: 1676200
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?
Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Miglioli M; Barbara L
J Clin Gastroenterol; 1988 Aug; 10(4):406-9. PubMed ID: 3418088
[TBL] [Abstract][Full Text] [Related]
12. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.
Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L
Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075
[TBL] [Abstract][Full Text] [Related]
13. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
Kam L; Cohen H; Dooley C; Rubin P; Orchard J
Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
[TBL] [Abstract][Full Text] [Related]
15. Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
Hanauer SB
Inflamm Bowel Dis; 1998 May; 4(2):79-83. PubMed ID: 9589293
[TBL] [Abstract][Full Text] [Related]
16. Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis.
Baum CA; Biddle WL; Miner PB
Dig Dis Sci; 1989 May; 34(5):758-60. PubMed ID: 2714149
[TBL] [Abstract][Full Text] [Related]
17. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
Segars LW; Gales BJ
Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
[TBL] [Abstract][Full Text] [Related]
18. Topical salicylate therapy (4-ASA and 5-ASA enemas).
Ginsberg AL
Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
[TBL] [Abstract][Full Text] [Related]
19. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
Barber GB; Lee DE; Antonioli DA; Peppercorn MA
Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789
[TBL] [Abstract][Full Text] [Related]
20. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis.
Mulder CJ; Fockens P; Meijer JW; van der Heide H; Wiltink EH; Tytgat GN
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):549-53. PubMed ID: 8823568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
